OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation
Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113740-113740
Open Access | Times Cited: 23
Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113740-113740
Open Access | Times Cited: 23
Showing 23 citing articles:
Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress
Md. Ataur Rahman, Abu Saim Mohammad Saikat, Md Saidur Rahman, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 458-458
Open Access | Times Cited: 26
Md. Ataur Rahman, Abu Saim Mohammad Saikat, Md Saidur Rahman, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 458-458
Open Access | Times Cited: 26
RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104562-104562
Closed Access | Times Cited: 20
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104562-104562
Closed Access | Times Cited: 20
The effects of flavored vaped e-liquids on cultured human macrophages derived from the central and peripheral nervous systems
Claire Bradley, I. Walker, Alex Kovach, et al.
Toxicology in Vitro (2025), pp. 106013-106013
Closed Access
Claire Bradley, I. Walker, Alex Kovach, et al.
Toxicology in Vitro (2025), pp. 106013-106013
Closed Access
Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: a review
Mahsa Akbari Oryani, Shamim Nosrati, Hossein Javid, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1377-1404
Closed Access | Times Cited: 11
Mahsa Akbari Oryani, Shamim Nosrati, Hossein Javid, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 3, pp. 1377-1404
Closed Access | Times Cited: 11
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment
Mahesh Koirala, Mario DiPaola
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1801-1801
Open Access | Times Cited: 3
Mahesh Koirala, Mario DiPaola
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1801-1801
Open Access | Times Cited: 3
The effects of statin therapy on brain tumors, particularly glioma: a review
Amjad Z. Alrosan, Ghaith Heilat, Zeinab Y. Al Subeh, et al.
Anti-Cancer Drugs (2023)
Open Access | Times Cited: 7
Amjad Z. Alrosan, Ghaith Heilat, Zeinab Y. Al Subeh, et al.
Anti-Cancer Drugs (2023)
Open Access | Times Cited: 7
Natural flavonoids alleviate glioblastoma multiforme by regulating long non-coding RNA
Xian Liu, Xinyu Xiao, Xue Han, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114477-114477
Open Access | Times Cited: 6
Xian Liu, Xinyu Xiao, Xue Han, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114477-114477
Open Access | Times Cited: 6
Recent advances in codelivery of curcumin and siRNA as anticancer therapeutics
Mehdi Sanati, Amir R. Afshari, Prashant Kesharwani, et al.
European Polymer Journal (2023) Vol. 198, pp. 112444-112444
Closed Access | Times Cited: 6
Mehdi Sanati, Amir R. Afshari, Prashant Kesharwani, et al.
European Polymer Journal (2023) Vol. 198, pp. 112444-112444
Closed Access | Times Cited: 6
Evaluation of the Antitumor Potential of Soloxolone Tryptamide against Glioblastoma Multiforme Using in silico, in vitro, and in vivo Approaches
Andrey V. Markov, Kirill V. Odarenko, Aleksandra V. Sen’kova, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 7, pp. 1008-1021
Open Access | Times Cited: 5
Andrey V. Markov, Kirill V. Odarenko, Aleksandra V. Sen’kova, et al.
Biochemistry (Moscow) (2023) Vol. 88, Iss. 7, pp. 1008-1021
Open Access | Times Cited: 5
Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme
Amit Sharma, Yulu Wang, Fangfang Ge, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Amit Sharma, Yulu Wang, Fangfang Ge, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Psidium guajava induces cytotoxicity in human malignant glioblastoma cell line: Role of reactive oxygen species
Azar Hosseini, Mohaddeseh Sadat Alavi, Amir Reza Shahraki, et al.
Toxicology in Vitro (2023) Vol. 89, pp. 105567-105567
Closed Access | Times Cited: 4
Azar Hosseini, Mohaddeseh Sadat Alavi, Amir Reza Shahraki, et al.
Toxicology in Vitro (2023) Vol. 89, pp. 105567-105567
Closed Access | Times Cited: 4
Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4
S670, an amide derivative of 3-O-acetyl-11-keto-β-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome
Yihui Yang, Li Wan, Liwen Ren, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 209-222
Closed Access | Times Cited: 4
Yihui Yang, Li Wan, Liwen Ren, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 209-222
Closed Access | Times Cited: 4
Autophagy Modulation and Its Implications on Glioblastoma Treatment
Johnny Chen, Andrea Salinas Rodriguez, Maximiliano Arath Morales, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8687-8703
Open Access | Times Cited: 4
Johnny Chen, Andrea Salinas Rodriguez, Maximiliano Arath Morales, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8687-8703
Open Access | Times Cited: 4
Autophagy in combination therapy of temozolomide and IFN-γ in C6-induced glioblastoma: role of non-coding RNAs
Hamideh Bashiri, Maryam Moazam-Jazi, Mohammad Reza Karimzadeh, et al.
Immunotherapy (2023) Vol. 15, Iss. 14, pp. 1157-1169
Closed Access | Times Cited: 3
Hamideh Bashiri, Maryam Moazam-Jazi, Mohammad Reza Karimzadeh, et al.
Immunotherapy (2023) Vol. 15, Iss. 14, pp. 1157-1169
Closed Access | Times Cited: 3
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access
Auraptene inhibits migration, invasion and metastatic behavior of human malignant glioblastoma cells: An
Seyed Hadi Mousavi, Mohammad Jalili‐Nik, Mohammad Soukhtanloo, et al.
PubMed (2024) Vol. 14, Iss. 3, pp. 349-364
Closed Access
Seyed Hadi Mousavi, Mohammad Jalili‐Nik, Mohammad Soukhtanloo, et al.
PubMed (2024) Vol. 14, Iss. 3, pp. 349-364
Closed Access
BCL2L13 Influences Autophagy and Ceramide Metabolism without Affecting Temozolomide Resistance in Glioblastoma
Courtney Clark, Amir Barzegar Behrooz, Simone C. da Silva Rosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Courtney Clark, Amir Barzegar Behrooz, Simone C. da Silva Rosa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Role of autophagy in modulating tumor cell radiosensitivity: Exploring pharmacological interventions for glioblastoma multiforme treatment
Pierre Bischoff, Jolie Bou-Gharios, G. Noël, et al.
Cancer/Radiothérapie (2024)
Open Access
Pierre Bischoff, Jolie Bou-Gharios, G. Noël, et al.
Cancer/Radiothérapie (2024)
Open Access
Recent Update on Anti-tumor Mechanisms of Valproic Acid in Glioblastoma Multiforme
Abulfazl Vatankhah, Sepehr Hoseinzadeh Moghaddam, Sadaf Afshari, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155636-155636
Closed Access
Abulfazl Vatankhah, Sepehr Hoseinzadeh Moghaddam, Sadaf Afshari, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155636-155636
Closed Access
Markedly divergent effects of Ouabain on a Temozolomide-resistant (T98G) vs. a Temozolomide-sensitive (LN229) Glioblastoma cell line
Heidrun Weidemann, Daniel Feger, Jan E. Ehlert, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Heidrun Weidemann, Daniel Feger, Jan E. Ehlert, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Application of RNA-based therapeutics in glioma: A review
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Progress in molecular biology and translational science (2023), pp. 133-161
Closed Access | Times Cited: 1
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Progress in molecular biology and translational science (2023), pp. 133-161
Closed Access | Times Cited: 1
Evaluation of the antitumor potential of soloxolone tryptamide against glioblastoma multiforme using in silico, in vitro and in vivo approaches
Andrey V. Markov, Kirill V. Odarenko, Aleksandra V. Sen’kova, et al.
Биохимия (2023) Vol. 88, Iss. 7, pp. 1237-1253
Closed Access
Andrey V. Markov, Kirill V. Odarenko, Aleksandra V. Sen’kova, et al.
Биохимия (2023) Vol. 88, Iss. 7, pp. 1237-1253
Closed Access
